Results

Total Results: over 10,000 records

Showing results for "drugs".

21. Key potentially inappropriate drugs in pediatrics: the KIDs list. | PSNet
    psnet.ahrq.gov/issue/key-potentially-inappropriate-drugs-pediatrics-kids-list
    September 23, 2020 - Study Emerging Classic Key potentially inappropriate drugs … Key potentially inappropriate drugs in pediatrics: the KIDs list. … This article describes the development of the Key Potentially Inappropriate Drugs in Pediatrics, or “ … The final KIDs List includes 67 drugs/drug classes; most require a prescription and are available in … Key potentially inappropriate drugs in pediatrics: the KIDs list.

22. S13 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s13.pdf
    October 01, 2007 - Historically, those who investigate the effects of mar- keted pharmaceuticals have focused on the risk … Unique Problems in the Study of Pharmaceuticals Exposure misclassification is a unique challenge in … Indeed, the confounders of concern are usually other drugs or other diseases. … In addition, studies of pharmaceuticals, especially stud- ies of the effectiveness of pharmaceuticals … CONCLUSIONS The goal of our research community is to optimize the use of pharmaceuticals by improving

23. Tamper-resistant drugs cannot solve the opioid crisis. | PSNet
    psnet.ahrq.gov/issue/tamper-resistant-drugs-cannot-solve-opioid-crisis
    May 01, 2019 - Commentary Tamper-resistant drugs cannot solve the opioid crisis. … Tamper-resistant drugs cannot solve the opioid crisis. … Tamper-resistant drugs cannot solve the opioid crisis.

24. Final Progress Report: Off-Label Prescribing: Comparative Evidence, Regulation, and Utilization (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/kesselheim-report.pdf
    January 01, 2024 - , neuropsychiatric drugs, and drugs for other rare diseases. … Second, I identified selected drugs in three target categories—neuropsychiatric drugs, oncologic drugs … , and drugs for other rare diseases. … orphan drugs and found that off-label uses predominate in orphan drugs used for popular “symptoms” … Strategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower

25. Using drug knowledgebase information to distinguish between look-alike-sound-alike drugs. | PSNet
    psnet.ahrq.gov/issue/using-drug-knowledgebase-information-distinguish-between-look-alike-sound-alike-drugs
    July 10, 2019 - Using drug knowledgebase information to distinguish between look-alike-sound-alike drugs … Using drug knowledgebase information to distinguish between look-alike-sound-alike drugs. … Look-alike, sound-alike drugs are a known safety risk and contribute to medication errors . … Using drug knowledgebase information to distinguish between look-alike-sound-alike drugs. … March 23, 2016 Look alike/sound alike drugs: a literature review on causes and solutions

26. Use of hepatotoxic drugs in chronic liver disease. | Digital Healthcare Research
    digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics-4
    January 01, 2023 - Use of hepatotoxic drugs in chronic liver disease. … Use of hepatotoxic drugs in chronic liver disease. J Patient Saf 2012 Jun;8(2):45-50.

27. Data Points #9: Utilization of antidiabetic drugs among Medicare beneficiaries with diabetes, 2006-2009 | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/diabetes-drugs-utilization/research

28. Making Healthcare Safer IV: Protocols for High-Risk Drugs: Reducing Adverse Drug Events Related to Anticoagulants | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/high-risk-drugs/protocol

29. A protocol for the safe use of hazardous drugs in the OR. | PSNet
    psnet.ahrq.gov/issue/protocol-safe-use-hazardous-drugs-or
    May 13, 2015 - Study A protocol for the safe use of hazardous drugs in the OR. … A protocol for the safe use of hazardous drugs in the OR. … Perioperative personnel often care for patients requiring hazardous drugs, and guidelines recommend … The protocol includes requirements for personal protective equipment for hazardous drugs, the use of … A protocol for the safe use of hazardous drugs in the OR.

30. Paramedics turn to expired drugs due to shortages. | PSNet
    psnet.ahrq.gov/issue/paramedics-turn-expired-drugs-due-shortages
    September 05, 2012 - Newspaper/Magazine Article Paramedics turn to expired drugs due to shortages. … Citation Text: Paramedics turn to expired drugs due to shortages. WBUR. August 8, 2012. … Cite Citation Citation Text: Paramedics turn to expired drugs … July 5, 2023 Nearly all thirty most frequently used emergency department drugs experienced … September 12, 2016 Despite federal legislation, shortages of drugs used in acute care

31. Out-of-Pocket Spending for Retail Prescribed Drugs by Age and Type of Prescription Drug Coverage, 2009 to 2018 (pdf file)
    meps.ahrq.gov/data_files/publications/st532/stat532.pdf
    December 01, 2020 - drugs have led to concerns about high, and rising, out-of- pocket costs for prescription drugs. … Among those who used prescription drugs, we examine the distribution of out-of-pocket spending for drugs … drugs. … Definitions Prescribed drugs Only prescribed drugs obtained from retail pharmacies, including mail … Note: Among people who obtained retail prescribed drugs.

32. Type of Drug & ADE (by drug-type) (pdf file)
    hcup-us.ahrq.gov/reports/statbriefs/sb158_appendix.pdf
    December 25, 2022 - 961.7 Poisoning by antiviral drugs 961.8 Poisoning by other antimycobacterial drugs 961.9 Poisoning … antiallergic and antiemetic drugs E933.0 Antiallergic and antiemetic drugs causing adverse effects in … 966.4 Poisoning by anti-Parkinsonism drugs E936.4 Anti-parkinsonism drugs causing adverse effects in … and other drugs and preparations for ear, nose, and throat 976.7 Poisoning by dental drugs topically … and other eczema due to drugs and medicines in contact with skin 693.0 Dermatitis due to drugs and

33. STATISTICAL BRIEF #532: Out-of-Pocket Spending for Retail Prescribed Drugs by Age and Type of Prescription Drug Coverage, 2009 to 2018
    meps.ahrq.gov/data_files/publications/st532/stat532.shtml
    December 01, 2020 - prescription drugs. … Among those who used prescription drugs, we examine the distribution of out-of-pocket spending for drugs … In 2018, half of uninsured people who obtained prescribed drugs spent $55 or less annually on their drugs … Definitions Prescribed drugs Only prescribed drugs obtained from retail pharmacies, including … Note: Among people who obtained retail prescribed drugs.

34. Characteristics of medication errors with parenteral cytotoxic drugs. | PSNet
    psnet.ahrq.gov/issue/characteristics-medication-errors-parenteral-cytotoxic-drugs
    July 01, 2017 - Study Characteristics of medication errors with parenteral cytotoxic drugs. … Characteristics of medication errors with parenteral cytotoxic drugs. … Characteristics of medication errors with parenteral cytotoxic drugs. … May 27, 2011 Computerized physician order entry of injectable antineoplastic drugs: an

35. Archived: Drug Use, Illicit: Primary Care Interventions for Children and Adolescents | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-use-illicit-primary-care-interventions-for-children-and-adolescents-march-2014
    March 11, 2014 - (Note: The NSDUH collected data on use of illicit drugs and nonmedical use of prescription drugs but … not over-the-counter drugs; thus, actual drug use [illicit and nonmedical use of all pharmaceuticals] … statement, “drug use” encompasses the general concepts of “illicit drug use” and “nonmedical use of pharmaceuticals … “Nonmedical use of pharmaceuticals” includes the use of prescribed medications for a purpose other than … , and more than 75,000 visits involved the nonmedical use of pharmaceuticals (3).

36. Product-related issues make error potential enormous with investigational drugs. | PSNet
    psnet.ahrq.gov/issue/product-related-issues-make-error-potential-enormous-investigational-drugs
    May 07, 2018 - Article Product-related issues make error potential enormous with investigational drugs … Citation Text: Product-related issues make error potential enormous with investigational drugs. … This article highlights numerous safety concerns surrounding investigational drugs and offers safe practice … Citation Citation Text: Product-related issues make error potential enormous with investigational drugs

37. Computerized physician order entry of injectable antineoplastic drugs: an epidemiologic study of prescribing medication errors. | PSNet
    psnet.ahrq.gov/issue/computerized-physician-order-entry-injectable-antineoplastic-drugs-epidemiologic-study
    October 19, 2022 - Study Computerized physician order entry of injectable antineoplastic drugs: an epidemiologic … Computerized physician order entry of injectable antineoplastic drugs: an epidemiologic study of prescribing … The incidence of prescribing errors for chemotherapy drugs remained relatively high in this study, at … Computerized physician order entry of injectable antineoplastic drugs: an epidemiologic study of prescribing

38. Adverse events associated with procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs. | PSNet
    psnet.ahrq.gov/issue/adverse-events-associated-procedural-sedation-and-analgesia-pediatric-emergency-department
    June 12, 2019 - procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs … procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs … They conclude that all patients receiving these drugs are at risk for adverse events. … procedural sedation and analgesia in a pediatric emergency department: a comparison of common parenteral drugs

39. General practitioners' risk literacy and real-world prescribing of potentially hazardous drugs: a cross-sectional study. | PSNet
    psnet.ahrq.gov/issue/general-practitioners-risk-literacy-and-real-world-prescribing-potentially-hazardous-drugs
    December 21, 2014 - General practitioners' risk literacy and real-world prescribing of potentially hazardous drugs … General practitioners’ risk literacy and real-world prescribing of potentially hazardous drugs: a cross-sectional … relative vs absolute risk, related to medical interventions) and prescribing of potentially hazardous drugs … found that practitioners with higher risk literacy prescribed significantly fewer potentially hazardous drugs … or Office Family Medicine Primary Care Ordering/Prescribing Errors Specific to High-Risk Drugs

40. Research Findings #44: Retail Drug Prices, Out-of-Pocket Costs, and Discounts and Markups Relative to List Prices: Trends and Differences by Drug Type and Insurance Status, 2011 to 2016 (pdf file)
    meps.ahrq.gov/data_files/publications/rf44/rf44.pdf
    October 01, 2019 - : 1) specialty drugs; 2) non-specialty single source drugs; 3) non-specialty originators (brand name … drugs that have lost patent protection); and 4) non-specialty generic drugs. … for specialty drugs ($12.15). … generic drugs to $38.75 for specialty drugs (figure 2b). … • Non-specialty single source drugs are brand name drugs with patent protection.